Portola Pharmaceuticals
AcquiredNovel therapeutics for cardiovascular and autoimmune diseases
Portola Pharmaceuticals was founded in 2003, is headquartered in South San Francisco, United States, lists 201–500 employees, and has $216.0M in recorded funding across 4 rounds.
- Headquarters
- South San Francisco, California
- Employees
- 201–500
- Founded
- 2003
- Business Model
- B2B
- Website
- portola.com
- Total Funding
- $216.0M
- Last Round
- $89.0M Venture RoundNov 2011
- Rounds
- 4
- Acquisition Date
- May 2020
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.
About
Portola Pharmaceuticals was a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for patients with acute and chronic cardiovascular, autoimmune, and inflammatory diseases. The company's lead programs centered on anticoagulation and thrombosis, with its most notable product being Andexxa (andexanet alfa), the first approved antidote for reversal of Factor Xa inhibitors including rivaroxaban and apixaban. Portola also developed Bevyxxa (betrixaban), a Factor Xa inhibitor approved for VTE prophylaxis. The company was founded by Charles J. Homcy and David Phillips and was headquartered in South San Francisco, California. Portola was acquired by Alexion Pharmaceuticals in 2020, and portola.com now redirects to the Alexion website.
Summary
Portola Pharmaceuticals is a Biotech company based in South San Francisco, United States, founded in 2003. It lists 201–500 employees. It has raised $216.0M in total across 4 rounds, most recently a $89.0M Venture Round in Nov 2011. Investors include Temasek, Eastern Advisors and D. E. Shaw group.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
May 2020
Sign up to see all 5 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/portola-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/portola-pharmaceuticals" alt="Portola Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>